No takes yet. Share an insight, caveat, or question.
Research reveals Fc receptor-triggered trogocytosis impacts tumor-targeting antibody efficacy in the tumor microenvironment, suggesting new therapeutic approaches.
Eruslanov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: